|
"Cancer Risk and Environmental Exposures to Nitrate, Pesticides, and Industrial C
|
Z01 CP010153
|
$696,133
|
$521,036
|
Ward
|
DCEG (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
$318,004
|
Aplan, Peter
|
CCR (NCI)
|
|
Antileukemic effort of NK cells in HCT for pediatric AML
|
1R01CA120583-01A2
|
$359,055
|
$359,055
|
LEUNG, WING
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS
|
5R01CA077683-08
|
$266,610
|
$266,610
|
Felix, Carolyn
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Asparagine Synthetase as a Biomarker for L-asparaginase Rx of Ovarian Cancer
|
Z01 BC 010823
|
$303,024
|
$60,605
|
Weinstein, John
|
CCR (NCI)
|
|
Biochemistry of Leukemia Virus Core Binding Factor
|
5R01CA058343-14
|
$405,444
|
$202,722
|
SPECK, NANCY
|
DARTMOUTH COLLEGE
|
|
Biology and Prognostic implications of Flt3 mutations in AML
|
5R01CA114563-03
|
$421,364
|
$210,682
|
MESHINCHI, SOHEIL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Bone Marrow Transplantation in Human Disease
|
2P01CA015396-32A1
|
$2,857,642
|
$857,293
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-36
|
$2,815,899
|
$28,159
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S1
|
$61,920
|
$1,858
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA033572-24S2
|
$103,852
|
$3,116
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA033572-24
|
$2,274,248
|
$68,227
|
KRONTIRIS, THEODORE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$1,245
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$1,379
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$2,323
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$2,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$115,265
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
5P30CA023108-29
|
$3,012,185
|
$30,122
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
$6,935
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Cancer Center Support Grant
|
3P30CA068485-12S1
|
$112,948
|
$1,129
|
Pietenpol, Jennifer
|
VANDERBILT UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA068485-12
|
$5,179,933
|
$51,799
|
Pietenpol, Jennifer
|
VANDERBILT UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-07S1
|
$85,134
|
$851
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA091842-07S2
|
$238,995
|
$2,390
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA091842-07
|
$3,978,214
|
$39,782
|
EBERLEIN, TIMOTHY
|
WASHINGTON UNIVERSITY
|
|
Cancer Center Support Grant
|
3P30CA022453-26S2
|
$79,378
|
$4,763
|
RUCKDESCHEL, JOHN
|
WAYNE STATE UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA022453-26
|
$2,427,748
|
$145,665
|
RUCKDESCHEL, JOHN
|
WAYNE STATE UNIVERSITY
|
|
CANCER CENTER SUPPORT GRANT (CCSG)
|
3P30CA022435-22S2
|
$1,304,917
|
$39,148
|
FOGARTY, JOHN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
Cancer Center Support Grant P30 CA77598-06
|
3P30CA077598-10S1
|
$89,196
|
$2,676
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Cancer Center Support Grant P30 CA77598-06
|
3P30CA077598-10S2
|
$120,409
|
$3,612
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Cancer Center Support Grant P30 CA77598-06
|
5P30CA077598-10
|
$3,404,916
|
$102,147
|
YEE, DOUGLAS
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Cell Therapy of Refractory Leukemia
|
5R01CA113482-02
|
$281,365
|
$140,683
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Childhood Cancer Survivor Study
|
5U24CA055727-13
|
$4,654,448
|
$930,890
|
Robison, Leslie
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Childhood Leukemia International Consortium (CLIC)
|
1R03CA132172-01
|
$62,413
|
$62,413
|
Buffler, Patricia
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Children's Oncology Group Chair's Grant
|
3U10CA098543-05S2
|
$450,000
|
$238,500
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Chair's Grant
|
5U10CA098543-05
|
$29,944,122
|
$15,870,385
|
REAMAN, GREGORY
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$3,105,715
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Clinical Genetic Studies of Familial and Hereditary Cancer Syndromes
|
Z01 CP010144
|
$2,033,740
|
$1,069,850
|
Greene
|
DCEG (NCI)
|
|
Clinical Significance of Residual Myeloid Leukemia
|
5R01CA115422-02
|
$255,555
|
$127,778
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Comprehensive Cancer Center Core Support Grant
|
3P30CA013148-36S1
|
$67,828
|
$1,357
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Comprehensive Cancer Center Core Support Grant
|
5P30CA013148-36
|
$5,898,083
|
$117,962
|
PARTRIDGE, EDWARD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Deficits in Facial Expression Recognition in Childhood Cancer Survivors
|
1R03CA128472-01
|
$92,338
|
$46,169
|
BONNER, MELANIE
|
DUKE UNIVERSITY
|
|
Determinants of Relapse Risk After BMT for ALL
|
1R01CA116660-01A2
|
$304,189
|
$304,189
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Developing FLT3-Targeted Therapy for Pediatric Leukemia
|
5K23CA111728-02
|
$140,130
|
$70,065
|
BROWN, PATRICK
|
JOHNS HOPKINS UNIVERSITY
|
|
Development of CpG oligodeoxynucleotides as adjuvant chemotherapy for ALL
|
5R03CA123554-02
|
$80,108
|
$40,054
|
Reid, Gregor
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Development of Recombinant Toxins for Treatment of Patients with Hematologic Mali
|
Z01 BC 010301
|
$405,903
|
$8,118
|
Kreitman, Robert
|
CCR (NCI)
|
|
Development of tyrosine phosphatase SHP-2 inhibitors
|
5F32CA119771-02
|
$55,852
|
$55,852
|
GUVENCH, OLGUN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
$290,700
|
Balis, Frank
|
CCR (NCI)
|
|
Duke Comp Cancer Ctr Core Support Grant
|
3P30CA014236-33S1
|
$84,062
|
$1,681
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Duke Comp Cancer Ctr Core Support Grant
|
5P30CA014236-33
|
$6,558,287
|
$131,166
|
LYERLY, HERBERT
|
DUKE UNIVERSITY
|
|
Effect of Antibodies/Chemotherapy on Childhood Leukemia
|
5K01CA101897-05
|
$139,320
|
$139,320
|
HERRERA, LARRY
|
TEMPLE UNIVERSITY
|
Total relevant funding to Childhood Leukemia for this search: $44,502,817
|